165 related articles for article (PubMed ID: 8671931)
1. Oral vitamin D3 pulse therapy for overt secondary hyperparathyroidism at pre-dialysis stage.
Watanabe Y; Inaguma D; Fukuzawa Y; Kumon S; Yamazaki C
Nephrol Dial Transplant; 1996 May; 11(5):910-1. PubMed ID: 8671931
[No Abstract] [Full Text] [Related]
2. Hyperparathyroidism in CAPD patients: therapy with pulse oral calcitriol.
Juergensen PH; Finkelstein FO; Cooper K; Santacroce S; Kliger AS
Adv Perit Dial; 1993; 9():257-9. PubMed ID: 8105938
[TBL] [Abstract][Full Text] [Related]
3. Oral 1,25-dihydroxyvitamin D3 minipulse therapy.
Okada K; Kinoshita Y; Takahashi S
Nephron; 1994; 67(1):121-2. PubMed ID: 8052357
[No Abstract] [Full Text] [Related]
4. Limitations of pulse oral calcitriol therapy in continuous ambulatory peritoneal dialysis patients.
Bechtel U; Mücke C; Feucht HE; Schiffl H; Sitter T; Held E
Am J Kidney Dis; 1995 Feb; 25(2):291-6. PubMed ID: 7847357
[TBL] [Abstract][Full Text] [Related]
5. [Vitamin D therapy in predialysis renal failure].
Ando R
Clin Calcium; 2004 Sep; 14(9):73-7. PubMed ID: 15577115
[TBL] [Abstract][Full Text] [Related]
6. Serial evaluation of parathyroid size by ultrasonography is another useful marker for the long-term prognosis of calcitriol pulse therapy in chronic dialysis patients.
Fukagawa M; Kitaoka M; Yi H; Fukuda N; Matsumoto T; Ogata E; Kurokawa K
Nephron; 1994; 68(2):221-8. PubMed ID: 7830860
[TBL] [Abstract][Full Text] [Related]
7. Pulse oral calcitriol for the treatment of hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis: preliminary observations.
Martin KJ; Ballal HS; Domoto DT; Blalock S; Weindel M
Am J Kidney Dis; 1992 Jun; 19(6):540-5. PubMed ID: 1595702
[TBL] [Abstract][Full Text] [Related]
8. Calcitriol pulse therapy is not more effective than daily calcitriol therapy in controlling secondary hyperparathyroidism in children with chronic renal failure. European Study Group on Vitamin D in Children with Renal Failure.
Ardissino G; Schmitt CP; Testa S; Claris-Appiani A; Mehls O
Pediatr Nephrol; 2000 Jul; 14(7):664-8. PubMed ID: 10912539
[TBL] [Abstract][Full Text] [Related]
9. [Vitamin D "pulse" therapy for secondary hyperparathyroidism due to long-term hemodialysis in patients with chronic kidney failure].
Akiba T
Nihon Rinsho; 1991 Dec; 49 Suppl():720-4. PubMed ID: 1808342
[No Abstract] [Full Text] [Related]
10. Cinacalcet cost and utility in dialysis patients.
Cohen E; Uribarri J
Semin Dial; 2005; 18(4):353-4. PubMed ID: 16076364
[No Abstract] [Full Text] [Related]
11. Randomized trial comparing pulse calcitriol and alfacalcidol for the treatment of secondary hyperparathyroidism in haemodialysis patients.
Kiattisunthorn K; Wutyam K; Indranoi A; Vasuvattakul S
Nephrology (Carlton); 2011 Mar; 16(3):277-84. PubMed ID: 21342321
[TBL] [Abstract][Full Text] [Related]
12. Conversion of oral alfacalcidol to oral calcitriol in the treatment of secondary hyperparathyroidism in chronic hemodialysis patients.
Rauscher S; Lafrance JP; Pichette V; Bell RZ; Desforges K; Lepage L; Ouellet G; Ouimet D; Leblanc M; Lamarche C; Bezzaoucha S; Vallee M
Int Urol Nephrol; 2017 Feb; 49(2):325-328. PubMed ID: 27822674
[TBL] [Abstract][Full Text] [Related]
13. Intraperitoneal Calcitriol for Treatment of Severe Hyperparathyroidism in Children with Chronic Kidney Disease: A Therapy Forgotten.
Chanchlani R; Ackerman S; Piva E; Harvey E
Perit Dial Int; 2016 11-12; 36(6):688-690. PubMed ID: 27903853
[TBL] [Abstract][Full Text] [Related]
14. Oral pulse therapy with vitamin D3 for control of secondary hyperparathyroidism.
Feinstein S; Algur N; Drukker A
Pediatr Nephrol; 1994 Dec; 8(6):724-6. PubMed ID: 7696113
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D therapy in children on dialysis.
Wesseling K; Salusky IB
Perit Dial Int; 2007; 27(6):651-3. PubMed ID: 17984426
[No Abstract] [Full Text] [Related]
16. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
17. Pulse oral calcitriol to treat hyperparathyroidism in 43 CAPD patients.
Juergensen P; Santacroce S; Mooraki A; Cooper K; Finkelstein FO; Kliger AS
Adv Perit Dial; 1994; 10():259-60. PubMed ID: 7999840
[TBL] [Abstract][Full Text] [Related]
18. Control of hyperparathyroidism with once weekly oral pulse calcitriol therapy in a CAPD patient.
Pavlovic D; Cala S; Jankovic N; Brzac HT
Perit Dial Int; 1995; 15(2):181-2. PubMed ID: 7612746
[No Abstract] [Full Text] [Related]
19. Randomized controlled trial to compare the efficacy and safety of oral paricalcitol with oral calcitriol in dialysis patients with secondary hyperparathyroidism.
Ong LM; Narayanan P; Goh HK; Manocha AB; Ghazali A; Omar M; Mohamad S; Goh BL; Shah S; Seman MR; Vaithilingam I; Ghazalli R; Rahmat K; Shaariah W; Ching CH;
Nephrology (Carlton); 2013 Mar; 18(3):194-200. PubMed ID: 23311404
[TBL] [Abstract][Full Text] [Related]
20. [A trial of suppressing secondary hyperparathyroidism by oral high dose therapy of 1, 25-dihydroxyvitamin D3].
Shigematsu T; Kawaguchi Y; Unemura S; Suzuki M; Yamamoto H; Morita T; Momose M; Ogawa A; Nakayama M; Miyahara T
Nihon Jinzo Gakkai Shi; 1989 Apr; 31(4):393-401. PubMed ID: 2787433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
